NCT02171637View on ClinicalTrials.gov

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

February 28, 2006

Conditions
Neoplasms
Interventions
DRUG

BIBW 2992

escalating doses

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02171637 - Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter